Investor profile
Morgan Cheatham
Fund of funds, Private equity, Venture capital & Partner and Head of Healthcare and Life Sciences at Breyer Capital, Limited Partner at First Close Partners
Morgan Cheatham is a Partner and Head of Healthcare and Life Sciences at Breyer Capital, whose known portfolio counts 10 companies.
Is Morgan Cheatham a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
Contacts
Affiliated funds' portfolios
Partner and Head of Healthcare and Life Sciences at Breyer Capital, whose known portfolio counts 10 companies
- Wander
- SandboxAQ
- Hemi Labs
- OpenEvidence
- Simplified Financial Solutions Company
- Network Bio
- Harbor Health
- Catena Labs
- Jarsy
- Soley Therapeutics
Limited Partner at First Close Partners, whose known portfolio counts 1 company
- HelloGuru
Investor Profile
Founders in the listed sectors AI, Consumer, FinTech and Healthcare, and focus areas Biotech, Crypto, Data Analytics and Digital Health fall inside that listing.
Stage-wise, the deals at Breyer Capital cluster around Growth, Pre-Seed and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Morgan Cheatham is worth approaching.
Colleagues
Jim Breyer
Founder & CEO
Austin, United States
Ed Zimmerman
Founding Partner
New York, United States
Richard Odior
Limited Partner
New York City, United States
Daniel Breyer
Partner
San Francisco, United States
Anthony Pergola
Partner
New York, United States
Ted Breyer
Partner
San Francisco, United States
Betsy Zimmerman
Co-Founder
New York, United States
Frequently asked questions
Who is Morgan Cheatham?
Morgan Cheatham is a fund of funds investor and private equity investor based in New York, United States, listed as Partner and Head of Healthcare and Life Sciences at Breyer Capital. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Morgan Cheatham personally.
What does Morgan Cheatham invest in?
Listed sectors include AI, Consumer, FinTech and Healthcare; listed focus areas include Biotech, Crypto, Data Analytics and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Morgan Cheatham invest at?
Breyer Capital appears in Growth, Pre-Seed and Seed rounds across its known deals, and Morgan Cheatham is listed there as Partner and Head of Healthcare and Life Sciences. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Morgan Cheatham listed at?
Morgan Cheatham is listed as Partner and Head of Healthcare and Life Sciences at Breyer Capital. 7 other people in the database share a firm with Morgan Cheatham.
How do I contact Morgan Cheatham?
An email address, a phone number and a LinkedIn page are on file for Morgan Cheatham. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal